Hodgkin’s lymphoma and non-Hodgkin’s lymphoma, are both pathological types of lymphoma. From a clinical point of view, Hodgkin’s lymphoma has a relatively good prognosis and is treated with a single treatment, mainly radiotherapy as well as chemotherapy. However, it depends on the specific analysis, for example, Hodgkin’s lymphoma in stage I and II can be cured by radiation therapy alone. For stage III and IV Hodgkin’s lymphoma, radiotherapy in addition to chemotherapy is required. The treatment of non-Hodgkin’s lymphoma depends on the specific type of pathology, whether it is inert lymphoma or aggressive lymphoma. If inert lymphoma, such as grade 1 or 2 of follicular lymphoma or some types of set cell lymphoma, can be treated by observation and waiting strategy, and no treatment is needed if there are no symptoms. Stage III and IV non-Hodgkin’s lymphoma should be treated with systemic therapy, plus local radiotherapy. If there is CD20 positivity, treatment with immunochemotherapy drugs, such as rituximab, is also added.